Table 5 |
||||||
|
Multivariable Cox regression model adjusted for age, arterial disease and cystatin C |
||||||
|
OM |
CVM |
N-VM |
||||
|
|
||||||
|
P-value |
HR (95% CI) |
P-value |
HR (95% CI) |
P-value |
HR (95% CI) |
|
|
Smoking |
0.02 |
3.6 (1.3-10.4) |
||||
|
SLICC >1 [25] |
0.01 |
3.8 (1.3-16.4) |
||||
|
aβ2GP1 |
0.02 |
3.6 (1.2-10.6) |
||||
|
Sjogrens syndrome B antibodies |
0.02 |
9.1e-7 (0-0.8) |
||||
|
Warfarin |
0.04 |
3.7 (1.1-11.9) |
||||
|
High sensitivity CRP |
0.01 |
1.6 (1.1-2.4) |
||||
|
Fibrinogen |
||||||
|
α-1-antitrypsine |
0.02 |
3.0 (1.4-6.4) |
0.04 |
3.3 (1.1-9.2) |
0.02 |
4.3 (1.4-12.7) |
|
Soluble vascular cell adhesion molecule 1 |
0.02 |
5.2 (1.3-18.8) |
||||
|
|
||||||
|
aβ2GP1, anti-β2 glycoprotein-1; SLICC, systemic lupus international collaborating clinics; CRP, C-reactive protein; HR, hazard ratio; OM, overall mortality; CVM, cardiovascular mortality; N-VM, non-vascular mortality. Only P-values ≤ 0.05 are presented. |
||||||
|
Gustafsson et al. Arthritis Research & Therapy 2012 14:R46 doi:10.1186/ar3759 |
||||||
